NeoCell Corporation Files for Patent Protection on Canine and Equine Collagen Joint Health Supplement

Newport Beach, California, April 18, 2006 - NeoCell Corporation announces the filing of patent protection on ArthroPet™ following a long-term, micro-research study that confirmed the effectiveness of the natural supplement made with kolla2®. Designed to relieve certain bone and joint conditions in canines and equines, ArthroPet™ is manufactured under the advanced, patented technology of kolla2® (U.S. Patent #6,838,440), an essential Type II Collagen. The results, determined by a veterinary surgical examiner and x-rays, showed that progression of the canines hip dysplasia had ceased and normal joint formation and mobility had resumed. For more information call NeoCell at 800-346-2922 or visit

Joanne Olshan
[email protected]

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.